The strains used in this study were obtained by experimental evolution as previously described [30 (link)] (Tables S1 and S2, available with the online version of this article). Briefly, P. aeruginosa PAO1 biofilms were repeatedly exposed to the QSI C-30 (100 µg ml−1), tobramycin (20 µg ml−1), or a combination of C-30 and tobramycin, in SCFM2, during 16 cycles. P. aeruginosa was maintained on tryptone soy agar (TSA, Neogen) and all overnight cultures were prepared in Lysogeny Broth (LB, Neogen). For each condition three independent replicate populations (lineages) were used. Whole populations of the evolved lineages were used for subsequent analyses.
Free full text: Click here